Pay in 4 interest-free payments of $7.30 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
A comprehensive health assessment ensures safety and identifies whether related lifestyle changes may be sufficient before turning to medication
It is administered once weekly via subcutaneous injection, starting at 0.25 mg for the first four weeks and gradually increasing to 0.5 mg, 1.0 mg, and up to 2.4 mg as needed, based on the patients response and treatment goals
With the emergence of an oral tablet alongside a once-weekly injectable Wegovy, patients may ask, Which option is better for me? While both target similar pathways, the decision is less about better and more about fit
M6: \(\beta\)=0.77, 95% CI 0.50, 1.03
tirzepatide So, how does orforglipron compare to other injectable weight loss medications , such as fellow GLP-1s semaglutide ( Wegovy ) and dual GLP-1/GIP medications like tirzepatide (Zepbound)
US$ 25.08
US$ 29.21
US$ 26.26
US$ 21.29
